<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75609">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01987544</url>
  </required_header>
  <id_info>
    <org_study_id>Telebike2013</org_study_id>
    <nct_id>NCT01987544</nct_id>
  </id_info>
  <brief_title>Effects of Ergometer Training With Telemonitoring in Patients With Chronic Obstructive Pulmonary Disease (COPD) After Exacerbation</brief_title>
  <acronym>COPD</acronym>
  <official_title>German: Effekte Eines Telemonitorisch überwachten Ergometertrainings Bei Patienten Mit Einer COPD Nach Exazerbation: Eine Prospektiv Randomisierte Studie</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karl Heinz Ruehle</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vitaphone GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut für Pneumologie Hagen Ambrock eV</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Home ergometer training combined with online monitoring and regular telephone support could
      prove to be a cost-effective method to improve physical performance and quality of life in
      COPD patients.

      The primary objective of the study is to demonstrate a significantly higher daily workout
      time in patients that are monitored during home ergometer training with telephone support
      compared to conventional home ergometer training. Consequently we expect an increased
      quality of life related to the illness and a decreasing BODE-Index. A post-interventional
      lower BODE-Index correlates with a reduced risk of hospitalisation and mortality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis: There will be an increased prevalence, morbidity and mortality of COPD during
      the next decades. On the other hand there is a clear correlation between life expectancy and
      physical activity in this disease. Telemedicine concepts promise new treatment strategies
      with favourable impact on the long-term process of COPD.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Training time</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients workout at home with a provided bicycle ergometer, the daily training target is 30 minutes. The training time is monitored online using a GSM module.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BODE-Index</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>The BODE-Index is a grading tool to assess the progress of COPD with a range of 0 to 10 points. A post-interventional lower BODE-Index correlates with a reduced risk of hospitalisation and mortality.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>CAT (COPD Assessment Test)</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>The CAT is a questionnaire to measure the impact of COPD on a person's life. The range is 0 to 40 points.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Self-Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 months of ergometer training under self control at home without any interventional motivation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Motivation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 months of ergometer training at home with telemonitoring and motivation phone calls once a week when training sessions drop below 20 minutes per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ergometer Training</intervention_name>
    <arm_group_label>Self-Control</arm_group_label>
    <arm_group_label>Motivation</arm_group_label>
    <other_name>Ergometer</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Motivation</intervention_name>
    <arm_group_label>Motivation</arm_group_label>
    <other_name>Telemonitoring</other_name>
    <other_name>Phone Calls</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD

        Exclusion Criteria:

          -  tumor diseases

          -  unstable coronary heart disease

          -  untreated cardiac valve disease

          -  incapable of giving consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Karl Heinz Rühle, Prof. MD</last_name>
    <phone>0049 2331 974</phone>
    <phone_ext>2005</phone_ext>
    <email>klinik-ambrock.pneumo@t-online.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ulrike Domanski</last_name>
    <phone>0049 2331 974</phone>
    <phone_ext>2080</phone_ext>
    <email>ulrike.domanski@helios-kliniken.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Helios Klinik Hagen</name>
      <address>
        <city>Hagen</city>
        <state>NRW</state>
        <zip>58091</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Heinz Rühle</last_name>
    </contact>
    <investigator>
      <last_name>Karl Josef Franke, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Georg Nilius, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 5, 2014</lastchanged_date>
  <firstreceived_date>November 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Institut für Pneumologie Hagen Ambrock eV</investigator_affiliation>
    <investigator_full_name>Karl Heinz Ruehle</investigator_full_name>
    <investigator_title>Head of Institut für Pneumologie Hagen Ambrock eV</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>telemonitoring</keyword>
  <keyword>training</keyword>
  <keyword>ergometer</keyword>
  <keyword>telemedicine</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
